Status:
COMPLETED
SPECT/CT in Endocrine and Neuroendocrine Tumors
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Endocrine and Neuroendocrine Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The value of fusion of functional and anatomical data has been described using several fusion techniques for various nuclear medicine procedures and morphologic imaging modalities (SPECT-CT, SPECT-MRI...
Detailed Description
The value of fusion of functional and anatomical data has been described using several fusion techniques for various nuclear medicine procedures and morphologic imaging modalities (SPECT-CT, SPECT-MRI...
Eligibility Criteria
Inclusion
- Patient referred for NM scintigraphy to assess the presence of endocrine or neuroendocrine tumors.
- Patient signed informed consent
Exclusion
- The study will not be performed in pregnant or lactating women.
- Patient will not be able or willing to tolerate the scan until its completion.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2006
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00230139
Start Date
January 1 2002
End Date
January 1 2006
Last Update
October 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical Center
Haifa, Israel